[1] 韩永继,郑思睿,周丹丹.黄蛭口服液抑制急性心肌梗死后心肌纤维化的临床观察[J].海南医学,2022,33(15):1939-1942.
[2] 郁静,侯旗旗,韩全乐,等.甘油三酯水平与中青年人群急性心肌梗死发病风险的相关性研究[J].中国循环杂志,2023,38(2):152-157.
[3] 张海军,陈会校,靳芳,等.PCI术后1年再发AMI患者预后影响因素研究[J].中国循证心血管医学杂志,2021,13(7):811-814,818.
[4] 赵兴洲,李靖,马竞,等.85岁高龄急性心肌梗死支架术后极重度血小板减少成功救治一例[J].中华老年心脑血管病杂志,2021,23(9):985-986.
[5] Mishra A,Singh M,Acker WW,et al.Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention[J]. J Cardiovasc Pharmacol,2019,74(2):82-90.
[6] 中国医师协会中西医结合医师分会,中国中西医结合学会心血管病专业委员会,中国中西医结合学会重症医学专业委员会,等.急性心肌梗死中西医结合诊疗指南[J].中国中西医结合杂志,2018,38(3):272-284.
[7] Sehested TSG, Carlson N, Hansen PW, et al. Reduced risk of gastrointestinal bleeding associated with proton pump inhibitor therapy in patients treated with dual antiplatelet therapy after myocardial infarction[J]. Eur Heart J,2019,40(24):1963-1970.
[8] 王传燕,倪雨花.急性心肌梗死病人PCI术后服药依从性的影响因素及预测模型构建[J].中西医结合心脑血管病杂志,2022,20(10):1904-1907.
[9] 赵莹莹,杨哲然,陈瑞霖,等.养心氏片联合双联抗血小板药物对急性心肌梗死经皮冠状动脉介入术后患者血小板聚集率影响[J].临床军医杂志,2023,51(6):579-581.
[10] 田雪,邢欣悦,李红.急性心肌梗死患者院内消化道出血的危险因素分析[J].心肺血管病杂志,2023,42(7):662-665.
[11] 罗方铱,陈雪,孙亚梅,等.急性心肌梗死并发消化道出血患者住院死亡的危险因素分析[J].中国医刊,2024,59(2):149-153.
[12] 郝晋瑶,程德均,王科程.冠心病PCI术后患者上消化道出血危险因素探讨[J].河北医学,2021,27(5):840-845.
[13] 田苗,范亚林,王梅英,等.PCI术后双联抗血小板治疗危险性急性上消化道出血的危险因素分析[J].河北医药,2020,42(16):2446-2450.
[14] 刘云,李艳秀,韩涛,等.急性心肌梗死术后并发消化道出血预测模型构建[J].武警后勤学院学报(医学版),2021,30(2):1-5.
[15] Khan M Y,Siddiqui W J,Alvarez C,et al.Reduction in postpercutaneous coronary intervention angina in addition to gastrointestinal events in patients on combined proton pump inhibitors and dual antiplatelet therapy: a systematic review and meta-analysis[J].Eur Gastro & Hepatol,2018,30(8):847-853.
[16] 陈娟,薛建波,康晓,等.急性消化性溃疡患者反复上消化道出血的危险因素研究[J].中国急救复苏与灾害医学杂志,2023,18(4):510-513,521. |